查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1470829

人工血管市場：按原料、產品、應用和最終用戶分類 - 全球預測 2024-2030

Vascular Graft Market by Raw Material (Biological Materials, Polyester, Polytetrafluoroethylene), Product (Coronary Artery By-Pass Graft, Endovascular Stent Graft, Hemodialysis Access Graft), Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年血管移植市場規模為35.1億美元，預計2024年將達37.7億美元，2030年將達57.9億美元，複合年成長率為7.39%。

血管移植是一種外科手術，使用取自身體其他部位的血管（也稱為移植物）將血流重定向到心臟中阻塞或部分阻塞的動脈。人造血管可由多種材料製成，包括聚四氟乙烯（PTFE）和聚氨酯等合成聚合物，以及膠原蛋白和人類或動物組織等生物材料。血管疾病的盛行率不斷增加，以及易患心血管疾病的老年人口不斷增加，導致血管移植的採用增加。然而，血管移植物植入後併發症的風險，例如移植物感染和血栓，可能會進一步阻礙血管移植物的採用。也就是說，開發先進生物相容性移植物的生醫材料研究的興起以及 3D血管造影術等血管成像技術的進步有可能為市場提供顯著的成長機會。

主要市場統計
基準年[2023] 35.1億美元
預測年份 [2024] 37.7億美元
預測年份 [2030] 57.9億美元
複合年成長率（%） 7.39%

由於原料的生物相容性和彈性，聚四氟乙烯血管移植物的使用迅速增加。

人體隱靜脈、臍靜脈等生物材料製成的人造血管因其生物相容性高、在人體內排斥的可能性低而廣泛應用。這些材料表現出合理的相容性、優異的長期通暢性和最小的抗原性。這些材料優選用於需要較小直徑的血管移植物，例如下肢繞道手術和冠狀動脈繞道手術手術。組織工程材料旨在模仿天然生物組織，具有高度生物相容性和生物分解性。組織工程移植物的目標是提供活自體骨移植，可以與患者一起生長、重塑和自我修復，同時降低移植物失敗、感染和排斥的風險。聚酯移植物具有高拉伸強度，但彈性往往不如天然血管。另一方面，PTFE雖然不如聚酯耐用，但具有較高的血液相容性，並且由於其彈性和優異的生物相容性而更常用。聚氨酯是一種有用的材料，因為它的硬度、彈性、彈性和生物穩定性等特性可以調節。

產品廣泛使用周邊血管移植物來恢復週邊動脈阻塞患者的血流

冠狀動脈繞道手術手術（CABG）是一種透過手術將冠狀動脈連接到主動脈或大靜脈以繞過心臟阻塞並維持血流的手術。當患者患有多發性動脈疾病、左主動脈疾病或冠狀動脈疾病的嚴重症狀時，通常會進行冠狀動脈繞道手術。血管內血管支架是由金屬網支撐的織物製成的管子，用於治療腹部主動脈血管瘤等疾病。是手術風險高或拒絕開放性手術的患者的首選。透過手術植入血液透析機通路移植物，為慢性腎臟病病患者的血液透析機治療提供持久且可靠的網路基地台。當患者的血管不適合創建動靜脈（AV）瘻管時，這是首選。週邊人造血管有助於恢復大腦和心臟以外區域的血流。它主要用於周邊動脈疾病，並已被證明對週邊動脈阻塞的患者有益。

應用：人造血管在心血管疾病治療的重要用途

動脈瘤被定義為血管壁的異常擴張或隆起，通常需要用血管移植物進行治療。這些移植物利用合成材料或自體組織繞過動脈瘤部位，有助於防止破裂和隨後的嚴重後果。該領域的新發展導致了用於治療腹主動脈瘤和胸主動脈瘤的血管內覆膜血管支架的發展，為傳統開放性手術提供了微創治療方法。心血管疾病是人造血管扮演重要角色的另一個領域。冠狀動脈疾病、周邊動脈疾病和大面積心肌梗塞都需要使用這些移植物。外科醫生在冠狀動脈繞道手術術 (CABG) 和周邊搭橋術等手術中使用移植物來恢復缺血區域的血流並降低心臟病發病率和死亡率。糖尿病引起週邊血管疾病，其特徵通常是周邊動脈閉塞和狹窄病變。人造血管，包括自體靜脈和合成材料，用於繞過這些阻塞，幫助恢復灌注並降低截肢的風險。腎衰竭，尤其是末期腎功能衰竭（ESRD），需要血液透析機來挽救生命。這個過程需要可靠的血管通路，透過創建動靜脈瘻管（AVF）或移植物（AVG）來實現連續透析通路。血管閉塞涉及血管的阻塞或閉合，是需要使用血管移植物的常見疾病。人造血管可作為恢復血液流動的管道，並且能夠承受身體的自然動態動力。根據阻塞的位置和嚴重程度，通常採用由生物材料、生物相容性材料或合成材料製成的腔內覆膜支架或旁路移植物。

最終使用者：血管移植物在門診手術中心（ASC）的重要應用

在門診手術中心 (ASC)，通常會進行搭橋手術和支架置入等手術，通常需要放置血管移植物。 ASG 專注於提供具有成本效益的高品質護理，從而提高康復率和患者滿意度，從而導致血管移植物的使用激增。隨著醫院進行越來越複雜的手術，對人造血管的需求持續成長。醫院使用的移植物需要與各種手術相容，因此需要多種選擇。傳統上，醫院專注於需要人造血管的複雜手術。然而，微創手術的增加和成本削減趨勢正在推動向 ASC 的轉變。

區域洞察

由於技術進步、醫療保健成本增加以及心血管疾病和糖尿病的流行，美洲的血管移植市場正在發展。在歐洲、中東和非洲地區，對監管合規性和安全措施的高度重視、強力的研發計劃、對血管移植物認知的提高以及醫療基礎設施的發展正在推動血管移植物使用效果的改善。在亞太地區，由於文明病的增加、醫療保健服務的加速擴張以及醫療技術的顯著進步，人工血管治療方法的發展正在取得進展。此外，模仿天然血管結構和成分的生物工程人造血管的發展預計將增加醫療專業人員對這種醫療程序的使用，以治療各種醫療狀況。

FPNV定位矩陣

FPNV定位矩陣對於評估血管移植市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對血管移植市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.人造血管市場規模及預測如何？

2.在血管人工血管市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.血管移植市場的技術趨勢和法規結構是什麼？

4.血管移植市場主要廠商的市場佔有率是多少？

5.進入血管移植市場的合適型態和策略性手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地與文明病的發生率正在增加。
      • 人們對微創手術的興趣日益濃厚
      • 血管移植臨床試驗增加
    • 抑制因素
      • 人工血管手術治療費用高
    • 機會
      • 改善血管移植物的設計和性能
      • 利用組織工程開發血管移植
    • 任務
      • 血管移植相關感染疾病
  • 市場區隔分析
    • 原料：聚四氟乙烯血管移植物的使用由於其生物相容性和彈性而迅速增加。
    • 產品：增加使用周邊血管移植物來恢復週邊動脈阻塞患者的血流
    • 應用：血管移植物在治療心血管疾病的重要用途
    • 最終使用者：血管移植物在門診手術中心（ASC）的重要應用
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章 人工血管市場：依原料分類

  • 生物材料
  • 聚酯纖維
  • 聚四氟乙烯
  • 聚氨酯

第7章人工血管市場：依產品

  • 冠狀動脈繞道手術繞道手術
  • 血管內覆膜血管支架
  • 血液透析機通路移植物
  • 周邊設備人工血管

第8章人造血管市場：依應用分類

  • 動脈瘤
  • 心血管
  • 糖尿病
  • 腎衰竭
  • 血管閉塞

第9章人工血管市場：依最終用戶分類

  • 門診手術中心
  • 醫院

第10章北美和南美人工血管市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太人工血管市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的人工血管市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Aquedeon Medical, Inc. 的 Duett 人工血管系統獲得 FDA IDE核准
    • Xeltis 的 aXess 血管移植開發獲得歐洲創新委員會的資助
    • Vygon 與 Carmat 合作開發用於人工心臟的人造血管
  • 戰略分析和建議

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-034B50030374

[189 Pages Report] The Vascular Graft Market size was estimated at USD 3.51 billion in 2023 and expected to reach USD 3.77 billion in 2024, at a CAGR 7.39% to reach USD 5.79 billion by 2030.

A vascular graft is a surgical process that redirects blood flow around a blocked or partially blocked artery in the heart by using a blood vessel taken from another part of your body, also known as a graft. Vascular grafts can be made from various materials, including synthetic polymers, such as polytetrafluoroethylene (PTFE) and polyurethane, and biological materials, such as collagen and human or animal tissue. The rise in the prevalence of vascular disorders and the rise in the geriatric population prone to cardiovascular diseases increases the adoption of vascular grafts. However, the risk of complications post-implantation of a vascular graft, such as graft infection and blood clots, may further hinder the adoption of the vascular graft. Nevertheless, the rise of biomaterial research for developing advanced, biocompatible grafts and the ongoing advancements in vascular imaging technologies such as 3D angiography offer potential for significant growth opportunities for the market.

KEY MARKET STATISTICS
Base Year [2023] USD 3.51 billion
Estimated Year [2024] USD 3.77 billion
Forecast Year [2030] USD 5.79 billion
CAGR (%) 7.39%

Raw Material: Burgeoning utilization of polytetrafluoroethylene-based vascular grafts owing to their biocompatibility and flexibility

The vascular grafts made from biological materials, including human saphenous and umbilical veins, are used widely due to their inherent compatibility and decreased chances of rejection in the human body. They display moderate compliance, excellent long-term patency, and minimal antigenicity. These materials are preferred for vascular grafts that require a smaller diameter, such as lower extremity bypass procedures or coronary artery bypass grafting. Tissue-engineered materials are engineered to mimic the natural body tissue and have the advantage of being biocompatible and biodegradable. The goal of tissue-engineered grafts is to provide a living, autologous construct that could grow with the patient, remodel, and repair itself while reducing the risk of graft failure, infection, and rejection. Polyester grafts exhibit enhanced tensile strength; they tend to be less compliant than natural blood vessels. PTFE, on the other hand, while not as durable as polyester, presents high hemocompatibility and is more commonly used due to its flexibility and superior biocompatibility. Polyurethane is a useful material due to its tunable properties, including variable hardness, flexibility, elasticity, and biostability.

Product: Proliferating usage of peripheral vascular graft for restoring blood flow in patients with blockages in the peripheral arteries

Coronary Artery Bypass Graft (CABG) is a surgically created connection between the coronary artery and aorta or larger veins that enables blood flow to bypass blockage in the heart. CABG is generally preferred when the patient has multiple artery diseases, left main coronary artery disease, or severe symptoms of coronary artery disease. An endovascular stent graft is a tube comprised of fabric supported by a metal mesh used to treat ailments such as abdominal aortic aneurysms. The patient population with a high surgical risk or refusal of open surgery prefers this. Hemodialysis access grafts are surgically implanted to provide a durable and reliable access point for hemodialysis treatments in patients with chronic kidney disease. They are preferred when patients' vessels are not suitable for creating arteriovenous (AV) fistula. Peripheral vascular grafts help restore blood flow to the parts of the body other than the brain and the heart. Used primarily in cases of peripheral artery disease, these grafts prove beneficial for patients with blockages in the peripheral arteries.

Application: Significant use of vascular grafts in treating cardiovascular diseases

Aneurysms, defined as abnormal extensions or bulges in blood vessel walls, often require intervention through vascular grafts. These grafts, utilizing synthetic materials or autogenous tissue, are used to bypass the aneurysmal site, helping to prevent rupture and subsequent serious consequences. New developments in the field have led to the creation of endovascular stent grafts for treating abdominal and thoracic aortic aneurysms, offering a less invasive alternative to traditional open surgery. Cardiovascular disease is another area where vascular grafts have a pivotal role. Coronary artery disease, peripheral artery disease, and massive myocardial infarction necessitate the use of these grafts. Surgeons utilize them for procedures such as coronary artery bypass grafting (CABG) and peripheral bypass procedures, restoring blood flow to ischemic areas, subsequently reducing cardiac morbidity and mortality. Diabetes often leads to peripheral vascular disease characterized by occlusive and stenotic lesions in the peripheral arteries. Vascular grafts, including autologous veins and synthetic materials, are used for bypassing these occluded sections, helping restore perfusion and reducing the risk of limb amputations. Renal or kidney failure, specifically end-stage renal disease (ESRD), requires life-saving hemodialysis. This process mandates reliable vascular access, achieved through the creation of arteriovenous fistulae (AVF) or grafts (AVG) for continuous dialysis access. Vascular occlusion, relating to blockage or closure of blood vessels, is a common condition necessitating the use of vascular grafts. Vascular grafts serve as conduits to restore blood flow, able to withstand the body's natural hemodynamic forces. Intraluminal stent grafts or bypass grafts, comprising biological, biocompatible, or synthetic materials, are often employed depending on the location and extent of occlusion.

End-User: Significant applications of vascular grafts in ambulatory surgical centers (ASCs)

Ambulatory Surgical Centers (ASCs) commonly perform procedures such as bypass surgery or placing stents, which often require the implantation of vascular grafts. The ASGs are witnessing a surge in vascular graft usage due to their focus on providing cost-effective, high-quality care that results in improved recovery and better patient satisfaction. Hospital-based procedures requiring vascular grafts remain high, with a constantly growing need due to complex surgeries being performed. Grafts deployed in the hospital setting often need to serve diverse surgical requirements, necessitating a broad portfolio of options. Hospitals have been traditionally more centered on complicated surgeries requiring vascular grafts. However, the rise in minimally invasive procedures and the trend towards cost-saving is shifting preferences towards ASCs.

Regional Insights

The vascular graft market is evolving in the Americas owing to technological advancements, rising healthcare expenditure, and the prevalence of cardiovascular disorders and diabetes in the region. Strong focus on regulatory compliance and safety measures, substantial research and development projects, increasing awareness regarding vascular grafts, and growing healthcare infrastructure encourage using vascular graft procedures to improve treatment outcomes in the EMEA region. Growing prevalence of lifestyle diseases and the accelerating expansion of healthcare services, significant medical technology advancements are resulting in the development of enhanced vascular graft procedures in the APAC region. Besides, the development of bioengineered vascular grafts that mimic the natural blood vessel structure and composition is anticipated to increase the use of this medical procedure by health professionals to treat various medical conditions.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Vascular Graft Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Vascular Graft Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Vascular Graft Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Affluent Medical, B. Braun Melsungen AG, Becton, Dickinson and Company, BIOVIC Sdn. Bhd., Boston Scientific Corporation, Cardinal Health Inc., Cook Medical, Inc., Corcym S.r.l., CryoLife, Inc., Endologix Inc., Getinge AB, Heart Medical Europe B.V., Japan Lifeline Co., Ltd., Lemaitre Vascular, Inc., Medtronic PLC, Merit Medical Systems, Inc., Perouse Medical SAS by Vygon SAS, Rua Life Sciences PLC, Shanghai Suokang Medical Implants Co. Ltd., Terumo Corporation, Vascular Graft Solutions Ltd., VUP Medical, W. L. Gore & Associates, Inc., and Xeltis B.V..

Market Segmentation & Coverage

This research report categorizes the Vascular Graft Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Raw Material
    • Biological Materials
      • Human Saphenous & Umbilical Veins
      • Tissue Engineered Materials
    • Polyester
    • Polytetrafluoroethylene
    • Polyurethane
  • Product
    • Coronary Artery By-Pass Graft
    • Endovascular Stent Graft
    • Hemodialysis Access Graft
    • Peripheral Vascular Graft
  • Application
    • Aneurysm
    • Cardiovascular
    • Diabetes
    • Kidney Failure
    • Vascular Occlusion
  • End-User
    • Ambulatory Surgical Center
    • Hospital
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Vascular Graft Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Vascular Graft Market?

3. What are the technology trends and regulatory frameworks in the Vascular Graft Market?

4. What is the market share of the leading vendors in the Vascular Graft Market?

5. Which modes and strategic moves are suitable for entering the Vascular Graft Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of lifestyle-related disorders globally
      • 5.1.1.2. Growing preference for minimally invasive procedures
      • 5.1.1.3. Rising number of clinical trials of vascular grafts
    • 5.1.2. Restraints
      • 5.1.2.1. High treatment cost of vascular graft procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvements in the design and performance of vascular grafts
      • 5.1.3.2. Development of tissue-engineered vascular grafts
    • 5.1.4. Challenges
      • 5.1.4.1. Infections associated with vascular grafts
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Raw Material: Burgeoning utilization of polytetrafluoroethylene-based vascular grafts owing to their biocompatibility and flexibility
    • 5.2.2. Product: Proliferating usage of peripheral vascular graft for restoring blood flow in patients with blockages in the peripheral arteries
    • 5.2.3. Application: Significant use of vascular grafts in treating cardiovascular diseases
    • 5.2.4. End-User: Significant applications of vascular grafts in ambulatory surgical centers (ASCs)
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Vascular Graft Market, by Raw Material

  • 6.1. Introduction
  • 6.2. Biological Materials
  • 6.3. Polyester
  • 6.4. Polytetrafluoroethylene
  • 6.5. Polyurethane

7. Vascular Graft Market, by Product

  • 7.1. Introduction
  • 7.2. Coronary Artery By-Pass Graft
  • 7.3. Endovascular Stent Graft
  • 7.4. Hemodialysis Access Graft
  • 7.5. Peripheral Vascular Graft

8. Vascular Graft Market, by Application

  • 8.1. Introduction
  • 8.2. Aneurysm
  • 8.3. Cardiovascular
  • 8.4. Diabetes
  • 8.5. Kidney Failure
  • 8.6. Vascular Occlusion

9. Vascular Graft Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Center
  • 9.3. Hospital

10. Americas Vascular Graft Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Vascular Graft Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Vascular Graft Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Aquedeon Medical, Inc. Receives FDA IDE Approval for the Duett Vascular Graft System
    • 13.3.2. Xeltis' aXess Vascular Graft Development Receives Funding From European Innovation Council
    • 13.3.3. Vygon Partners with Carmat to Develop a Vascular Graft for an Artificial Heart
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. VASCULAR GRAFT MARKET RESEARCH PROCESS
  • FIGURE 2. VASCULAR GRAFT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. VASCULAR GRAFT MARKET DYNAMICS
  • FIGURE 7. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. VASCULAR GRAFT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. VASCULAR GRAFT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VASCULAR GRAFT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR GRAFT MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HUMAN SAPHENOUS & UMBILICAL VEINS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HUMAN SAPHENOUS & UMBILICAL VEINS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR GRAFT MARKET SIZE, BY TISSUE ENGINEERED MATERIALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL VASCULAR GRAFT MARKET SIZE, BY TISSUE ENGINEERED MATERIALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYESTER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYESTER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYURETHANE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CORONARY ARTERY BY-PASS GRAFT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CORONARY ARTERY BY-PASS GRAFT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HEMODIALYSIS ACCESS GRAFT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HEMODIALYSIS ACCESS GRAFT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PERIPHERAL VASCULAR GRAFT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PERIPHERAL VASCULAR GRAFT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ANEURYSM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL VASCULAR GRAFT MARKET SIZE, BY KIDNEY FAILURE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL VASCULAR GRAFT MARKET SIZE, BY KIDNEY FAILURE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL VASCULAR GRAFT MARKET SIZE, BY VASCULAR OCCLUSION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL VASCULAR GRAFT MARKET SIZE, BY VASCULAR OCCLUSION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HOSPITAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 285. FINLAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 286. FINLAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 287. FINLAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 288. FINLAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 295. FRANCE VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 296. FRANCE VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 297. FRANCE VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 298. FRANCE VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 305. GERMANY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 306. GERMANY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 307. GERMANY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 308. GERMANY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 315. ISRAEL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. ISRAEL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. ISRAEL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 318. ISRAEL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 325. ITALY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 326. ITALY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 327. ITALY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 328. ITALY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 333. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 334. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 335. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 336. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 337. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 338. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 343. NIGERIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 344. NIGERIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 345. NIGERIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 346. NIGERIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 347. NIGERIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 348. NIGERIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 349. NORWAY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 350. NORWAY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 351. NORWAY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 352. NORWAY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 353. NORWAY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 354. NORWAY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 355. NORWAY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 356. NORWAY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 357. NORWAY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 358. NORWAY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 359. POLAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 360. POLAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 361. POLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 362. POLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 363. POLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 364. POLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 365. POLAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 366. POLAND VAS